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ABSTRACT
Purpose: To assess the contemporary prevalence of trachoma in Brazil’s non-indigenous popula-
tion, surveys of those thought to be at greatest risk of disease were conducted.
Methods: Rural census tracts of non-indigenous population from nine mesoregions were selected 
to compose the survey evaluation units (EUs) by considering previously endemic municipalities at 
greatest risk of trachoma. In each of the nine EUs, we conducted a population-based prevalence 
survey. Every resident of selected households aged � 1 year was examined for trachomatous 
inflammation — follicular (TF) and trachomatous trichiasis (TT). Additionally, data were collected on 
household-level access to water, sanitation, hygiene (WASH) and education.
Results: A total of 27,962 individuals were examined across nine EUs. The age-adjusted TF pre-
valence in 1–9-year-olds was <5% in each EU. The age- and gender-adjusted prevalence of TT 
unknown to the health system in ≥15-year-olds was <0.2% in eight EUs; in one EU, it was 0.22%. The 
median number of households surveyed per EU with access to an improved drinking water source 
within a 30-minute roundtrip of the house was 66%. School attendance was >99% of surveyed 
children.
Conclusions: The prevalence of TF was well below the target for elimination as a public health 
problem in all EUs. Because EUs surveyed were selected to represent the highest-risk non- 
indigenous areas of the country, TF prevalence is unlikely to be ≥5% in non-indigenous populations 
elsewhere. In one EU, the prevalence of TT was above the target threshold for elimination. Further 
investigation and possibly improvement in TT surgical provision are required in that EU.
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Introduction
Trachoma is a chronic inflammatory disease of the eye 
caused by the intracellular bacterium Chlamydia tra-
chomatis. Active (inflammatory) trachoma is charac-
terized by the formation of conjunctival follicles, which 
resolve spontaneously after infection is cleared. Ocular 
C. trachomatis is thought to be primarily transmitted 
from person to person by transfer of ocular and nasal 
secretions during direct contact between individuals, 
via eye-seeking flies or in fomites, such as face cloths or 
pillow cases,1–4 As such, trachoma disproportionately 
affects poor communities where resources limit perso-
nal hygiene and sanitation.5–7 Repeated infections lead 
to conjunctival scarring which can, in severe cases, 
cause entropion (where the eyelid margin folds in 
towards the eye) and trichiasis (where the eyelashes 
touch the eyeball). Eyelash abrasion damages the cor-
nea, which reduces visual acuity and may lead to 
blindness.8 Many rounds of reinfection are thought to 
be needed to develop significant conjunctival 
scarring,9so trachoma poses a threat to sight only 
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when ocular C. trachomatis occurs commonly within 
children; isolated cases of trachoma outside endemic 
areas are uncommon.10
The likely public health impact of trachoma is com-
monly assessed using the World Health Organization 
(WHO) simplified grading system. This is a set of five 
signs which covers the early (trachomatous inflammation 
— follicular [TF], trachomatous inflammation — intense 
[TI]) and late (trachomatous scarring [TS], trachomatous 
trichiasis [TT], corneal opacity [CO]) stages of 
trachoma.11,12
In 2010, trachoma was thought to be responsible for 
visual impairment in 1.4 million people, and irreversible 
blindness in another 450,000, worldwide,13 In March 
2019, it was estimated that 142 million people lived in 
trachoma-endemic areas worldwide,14 WHO and part-
ners have targeted trachoma for elimination as a public 
health problem globally. To declare elimination, coun-
tries must meet three criteria: (1) a prevalence of TF 
among children aged 1–9 years <5% in each formerly- 
endemic district; (2) a prevalence of TT unknown to the 
health system in people aged ≥15 years <0.2% in each 
formerly-endemic district; and (3) a defined strategy to 
identify and manage incident TT cases.15 Collaborations 
have been developed and best-practice guidance pub-
lished to support countries to estimate prevalence in 
suspected-endemic areas.16–19
A centralized model of care for the control of tra-
choma began in Brazil in 1923 and continued until 1998, 
delivered by the Federal Government through vertical 
campaigns. Trachoma surveillance and control activities 
in Brazil have declined since the 1970s, although, 
according to the prevalence survey conducted from 
1974–1976, some high-prevalence states remained, espe-
cially in the North region.20 Trachoma was considered 
eliminated in the state of São Paulo in the 1970s, and this 
was subsequently assumed to be true for the entire 
country. The disease was neglected, and deprioritised 
from Ministry of Health surveillance protocols. At the 
beginning of the 2000s, in order to understand the 
burden of trachoma among children, the Ministry of 
Health surveyed a sample of schools in 1,514 municipa-
lities known to have a high proportion of people living in 
resource-poor settings. The survey of school children 
included indigenous children who are thought to be at 
higher risk of trachoma.21–23 All cases found in the 
survey were treated with antibiotics to proactively con-
trol disease and reduce transmission,24 In seven of 19 
(37%) of surveyed states, prevalence of TF among exam-
ined school children was ≥5%.25–27
These findings gave trachoma visibility in the 2000s, 
triggering a strengthening of trachoma surveillance and 
control activities nationally.28 Cases found in 
surveillance activities and/or campaigns started to be 
reported in the Brazil Information System for 
Notifiable Diseases (SINAN) and cases were monitored 
temporally. The current strategy for eliminating tra-
choma in Brazil consists of active case finding and con-
tact tracing to reduce transmission of infection in 
endemic areas through antibiotic treatment of indivi-
duals with active trachoma and their contacts.24
SINAN data from almost 1,000 municipalities that 
performed trachoma surveillance activities from 2008– 
16 show a sharp decrease in the percentage of trachoma 
cases found over that period. However, because tra-
choma disproportionately affects impoverished commu-
nities where public health service access is poor, 
sampling methodologies that are not population-based, 
such as school sampling or disease notification by clin-
ical staff, risk introducing bias. Given this limitation, two 
population-based household surveys were conducted in 
the states of Pernambuco and Tocantins in 2014 and 
2015.5 However, these surveys were not designed to 
current international standards; in particular, graders 
were not standardised.17 For those reasons, and because 
they were carried out in only two states, further studies 
with a larger geographical scope and following the meth-
odological standards set by WHO16 were deemed to be 
necessary to support a future claim of elimination of 
trachoma as a public health problem in Brazil.
The aim of this study was to assess whether disease 
prevalence targets for trachoma elimination as a public 
health problem had been met in the non-indigenous 
Brazilian population in nine areas thought to be at risk 
of trachoma. Here, we describe the methodology used 
and the results obtained.
Materials and methods
Study design
A cross-sectional observational study was conducted in 
2018–9 to estimate the prevalence of TF in children aged 
1–9 years and the prevalence of TT in adults aged ≥15 
years in supposedly endemic areas. The design of each 
survey conformed with WHO recommendations, being 
based on that of the Global Trachoma Mapping Project 
(GTMP)16,17,19 with additional refinements developed 
by Tropical Data (www.tropicaldata.org).
The project was developed by the Oswaldo Cruz 
Foundation and the Health Surveillance Secretariat of 
the Ministry of Health (SVS/MS) and revised and imple-
mented with the support of Tropical Data. The protocol 
was approved by the Research Ethics Committee of the 
Oswaldo Cruz Foundation (Declaration No. 2,742,820) 
and the Pan American Health Organization (2018–06- 
2 C. L. SZWARCWALD ET AL.
0045). Tropical Data survey support was approved by 
the London School of Hygiene & Tropical Medicine 
Observational Ethics Committee (16105).
Definition and selection of evaluation units
Brazil is divided by the Brazilian Institute of Geography 
and Statistics into different geographical units: macro-
regions, mesoregions and microregions (which have 
geographical but no political or administrative signifi-
cance); and states and municipalities (which do have 
political and/or administrative significance). 
Municipalities are subdivided into census tracts, which 
are classified as rural or urban and indigenous or non- 
indigenous.
Data from prevalence surveys and pro-active search 
of trachoma cases carried out in some Special 
Indigenous Health Districts point to high levels of tra-
choma prevalence in the indigenous population, higher 
than those of Brazil’s non-indigenous population.27,28 
However, the demographic characteristics of the indi-
genous population, the geographical spread of indigen-
ous villages in the Brazilian territory, the specificities 
related to the organization of health services and to the 
research approval process, which needs approval by the 
National Research Ethic Commission (CONEP) and 
authorization by the National Indigenous Foundation 
(FUNAI) for all team members to enter indigenous 
lands, led us to divide the project in two: the first in 
the non-indigenous population (described herein) and 
the second in the indigenous population. This second 
project component will be carried out as a subsequent 
package of work.
Non-indigneous rural census tracts thought to be at 
epidemiological or social risk of trachoma were sub-
jected to a preliminary desk evaluation. 
Epidemiological risk was defined as TF prevalence in 
school children >10% in the surveys which took place 
from 2002–200827 or large proportions of children 
found to have TF in surveillance activities undertaken 
from 2008–2016. Social risk was defined by poverty and 
sanitation indicators: (1) mean nominal monthly 
income of people aged ≥10 years less than one-quarter 
of the minimum wage; and (2) <30% of households 
having a piped water supply. For the purposes of the 
survey, evaluation units (EUs) were defined at the 
mesoregion level. Eight mesoregions with at least one 
municipality meeting the criteria for epidemiological 
risk and with the largest number of non-indigenous 
census tracts at social risk among all state mesoregions 
were selected in the following states: Acre, Amazonas, 
Roraima, Pará, Maranhão, Ceará, Alagoas and 
Pernambuco. Additionally, to include an EU not 
previously considered to be trachoma-endemic, one 
mesoregion was selected in the state of Bahia meeting 
the criteria for social risk of trachoma but without any 
municipalities meeting the definition of epidemiological 
risk.
In each EU, a two-stage sampling strategy was imple-
mented. In the first stage, 30 non-indigenous rural clus-
ters were selected systematically with probability 
proportional to their resident population size, deter-
mined by the 2010 census.29 Within each cluster, for 
the second sampling stage, about 30 households were 
selected by compact segment sampling. This involved 
the cluster being subdivided into segments of 30 neigh-
bouring households (or the nearest practical approxima-
tion of 30 households) and selection, by simple random 
sampling, of one segment. All households in the selected 
segment were invited to participate, leading to inclusion 
of a total of about 900 households in each EU.
Data collection
Field work was carried out in three EUs from 
September–December 2018. Field work in the remaining 
six EUs took place between August–October 2019. Field 
teams each consisted of a recorder, a trachoma grader, 
and a local community health agent, who accompanied 
the team to facilitate fieldwork at the selected sites. All 
team members were standardised on the protocol pro-
cedures. Trachoma graders and recorders were standar-
dized according to WHO recommendations and 
Tropical Data manuals.30
Additionally, field teams were supervised by two 
supervisors and two ophthalmologists supported the 
evaluation and referral of TT cases to health services.
On approaching each selected household, contact was 
made with the household head and residents, and the 
study objectives, procedures, and the importance of 
participation were explained. All residents aged one 
year or more were invited to participate. Before taking 
part, each adult resident (≥18 years) was asked to read 
the Free and Informed Consent Terms and give their 
written consent to participate. Adults also consented to 
the participation of residents aged <18 years under their 
responsibility. For residents aged 7–17 years, the Terms 
of Assent were presented and signed when they agreed 
to participate.
After consenting to participate in the research, the 
household’s GPS coordinates were captured and an 
interview was conducted with a key informant concern-
ing household availability of water for drinking and 
washing and type of sanitation and handwash facilites 
(WASH variables). This questionnaire was translated 
from the Tropical Data household questionnaire, itself 
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adapted from the WHO/UNICEF Joint Monitoring 
Programme (JMP) questionnaire, and adapted (with 
minimal modifications) to suit the Brazilian setting. 
During the interview, household heads were asked 
whether they received monthly visits from community 
health agents.
Demographic information was collected about all 
residents (both present and absent) aged ≥1 year. 
Children aged 5–9 years were asked whether they reg-
ularly attended school. When one or more residents 
were absent, one return visit at the end of the day was 
scheduled.
Data were recorded by the recorder using the 
Tropical Data smartphone application. Data were 
encrypted and transmitted to secure Cloud-based ser-
vers for cleaning, storage and analysis by the Tropical 
Data data team in collaboration with the Oswaldo Cruz 
Foundation and the Ministry of Health. This system 
enabled real-time fieldwork monitoring and adherence 
to protocols previously agreed.
Clinical examination
Clinical grading was conducted by graders who had 
successfully completed the Tropical Data training pro-
gramme and achieved an inter-grader agreement (IGA) 
kappa score of ≥0.7 compared to a certified Tropical 
Data grader trainer in the grading of 50 school children 
of whom at least 10% had TF.30 School children were 
pre-screened the week before the IGA to ensure there 
were sufficient cases of TF, in line with Tropical Data 
guidelines. External examination of both eyes of all 
consenting residents aged ≥1 year was undertaken 
using 2.5× magnifying loupes and ambient or torch 
illumination. Presence or absence of TT, TF and TI, 
defined according to the WHO simplified grading 
system,11 was recorded for each examined eye.
Where TF or TI were identified, the grader explained 
the finding to the individual or their parent/guardian 
and offered management with azithromycin at no cost to 
the participant. Children with TF or TI and their house-
hold members received antibiotics according to age and 
weight,31 as regulated by the Health Surveillance 
Secretariat, Ministry of Health.32
When TT was identified, the upper tarsal conjunctiva 
was examined for signs of TS and additional questions 
were asked to identify whether or not that individual had 
previously been offered management (i.e., whether they 
were “unknown to the health system”).33
Contact information of TT cases was recorded and 
sent to local health authorities – the Municipal and State  
Health Secretariats – responsible for referring them to 
ophthalmological assessment and to surgery if needed.
The teams were also trained to deliver specific health 
education actions for the control and prevention of 
trachoma. These educational actions focused on 
improving personal hygiene, with an emphasis on 
encouraging facial cleanliness and other forms of disease 
prevention.
Data analysis
The complex sampling design was considered in the 
statistical analysis. Adjusted prevalence estimates were 
calculated in the statistical software R using Tropical 
Data algorithms, which are based on those of the 
GTMP17 and produce EU-level means of adjusted clus-
ter-level proportions. Prevalence of TF in those aged 1–9 
years was adjusted for age in one-year bands. Prevalence 
of TT in those aged ≥15 years was adjusted for gender 
and age in five-year bands. The 2010 census was used for 
age and gender adjustments.29 Analysis code is available 
at https://github.com/itidat/tropical-data-analysis- 
public. WASH variables were aggregated according to 
the WHO/UNICEF JMP definitions of improved water, 
sanitation and hygiene facilities. Because of the very 
small numbers of cases identified, no household-level 
disease association analyses were conducted.
Results
Population surveyed
In each EU, about 900 households (range: 898–1097) 
were included. In the nine EUs combined, 31,556 indi-
viduals aged ≥1 year were enumerated, of whom 27,962 
were examined (Table 1).
Clinical signs
The number of children aged 1–9 years examined was 
5,984 and 29 cases of TF (right and/or left eye) were 
found (Table 2).
The prevalence of TF among children aged 1–9 
years was low in all EUs surveyed. Prevalence ranged 
from 0.0% in Vale do Juruá to 1.0% in Nordeste 
Paraense (95%CI 0.3–1.9). All nine EUs had TF pre-
valence estimates well below the 5% threshold for 
elimination as a public health problem (Table 2).
The total number of people aged ≥15 years examined 
was 18,494, with 18 cases of TT found. Of these, 6 were 
known (meaning that the individuals reported having 
previously been offered management by a health 
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worker) and 12 were unknown to the health system 
(Table 3).
In eight of the nine EUs, the prevalence of TT 
unknown to the health system was below the elimination 
threshold of 0.2%.15 In the EU Noroeste Cearense, 
located in Ceara State, a prevalence of 0.22% was 
recorded (Figure 1).
Household-level data
Data collected on household-level access to WASH, 
health care and education are presented by EU in 
Table 4. Although the proportions of households with 
piped water were very low, ranging from 1–23%, the 
proportions that had improved drinking water sources 
in the household were much higher, with values > 70% 
in three EUs. The percentages of households with 
improved water source less than a 30-minute journey 
from the house had a similar distribution (median: 66%, 
range: 43–86%). The proportion of households with 
‘improved latrines’ according to WHO/UNICEF JMP 
criteria was variable between EUs: in three EUs, <40% 
of households had improved latrines, whereas in four 
other EUs, >80% of households had improved latrines.
Table 1. Number of people (≥1 years) enumerated, absent, refused and examined during trachoma surveys in Brazil, 2018–19.
Evaluation Unit State Enumerated Absent at the time of visit Long-term Absence* Refused Examined
Vale do Juruá Acre 3579 213 151 17 3198
Sudoeste Amazonense Amazonas 4334 309 242 28 3755
Norte de Roraima Roraima 2932 192 125 31 2584
Nordeste Paraense Pará 3958 237 179 37 3505
Leste Maranhense Maranhão 3429 170 132 33 3094
Noroeste Cearense Ceará 3089 146 124 40 2779
Sertão Pernambucano Pernambuco 3191 306 10 67 2808
Sertão Alagoano Alagoas 3827 277 164 113 3273
Vale São Franciscano da Bahia Bahia 3217 115 112 24 2966
*Long-term absence is defined as those not likely to return to the house the evening immediately after the teams visit, for example those staying away for work, 
travel or hospitalisation
Table 2. Prevalence of TF in children aged 1–9 years in selected evaluation units of Brazil, 2018–9.
Evaluation Unit State
Number of 1–9-year-olds 
examined
Number of 1–9-year-olds 
with TF




Vale do Juruá Acre 682 0 0.00 0.00–0.00
Sudoeste Amazonense Amazonas 1045 8 0.67 0.13–1.47
Norte de Roraima Roraima 591 5 0.62 0.10–1.35
Nordeste Paraense Pará 764 9 0.96 0.29–1.88
Leste Maranhense Maranhão 620 1 0.13 0.00–0.39
Noroeste Cearense Ceará 554 3 0.58 0.00–1.50
Sertão Pernambucano Pernambuco 466 2 0.20 0.00–0.51
Sertão Alagoano Alagoas 648 0 0.00 0.00–0.00
Vale São Franciscano da 
Bahia
Bahia 614 1 0.08 0.00–0.24
*Adjusted to 2010 census data in one-year age bands.29 
TF: trachomatous inflammation — follicular.
Table 3. Prevalence of trachomatous trichiasis unknown to the health system in people aged ≥15 years in Brazil, 2018–9.
Evaluation Unit State
Number of ≥15-year- 
olds examined
Number of TT cases unknown to the health 
system in ≥15-year-olds





Vale do Juruá Acre 2002 0 0.00 0.00–0.00
Sudoeste 
Amazonense
Amazonas 2226 0 0.00 0.00–0.00
Norte de Roraima Roraima 1663 1 0.05 0.00–0.15
Nordeste Paraense Pará 2312 0 0.00 0.00–0.00
Leste Maranhense Maranhão 2035 0 0.00 0.00–0.00
Noroeste Cearense Ceará 1971 7 0.22 0.06–0.44
Sertão 
Pernambucano
Pernambuco 2058 2 0.05 0.00–0.12




Bahia 1997 2 0.05 0.00–0.13
* Unknown to the health system (excluding cases for which management had previously been offered by a health worker); adjusted to 2010 census data for 
gender and age in five-year age bands.29 
TT: trachomatous trichiasis.
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Figure 1. Trachomatous trichiasis (TT) unknown to the health system prevalence in ≥15-year-olds in evaluation units surveyed for 
trachoma in Brazil, 2018–9. The prevalence of trachomatous inflammation—follicular was <5% in all nine EUs. AC: Vale do Juruá; AM: 
Sudoeste Amazonense; RR: Norte de Roraima; PA: Nordeste Paraense; MA: Leste Maranhense; BA: Vale São Franciscano da Bahia; AL: 
Sertão Alagoano; PE: Sertão Pernambucano; CE: Noroeste Cearense. The boundaries and names shown and the designations used on 
this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization or the Pan American 
Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation 
of its frontiers or boundaries.





% households with improved 





% of households receiving 
monthly visits from community 
health workers
% of children from 5 to 
9 years old who are in 
school
Vale do Juruá Acre 901 71 36 63 99
Sudoeste  
Amazonense
Amazonas 903 76 36 77 98
Norte de Roraima Roraima 898 66 86 36 95
Nordeste 
Paraense
Pará 898 63 62 61 100
Leste 
Maranhense
Maranhão 900 67 36 74 99
Noroeste 
Cearense
Ceará 900 86 92 64 99
Sertão  
Pernambucano
Pernambuco 1097 54 82 86 99




Bahia 900 47 88 66 99
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Two-thirds of households surveyed received monthly 
visits from community health workers (median 65%, 
range: 36–86%). Only one EU had <60% of households 
visited monthly by community health workers (Norte de 
Roraima, 36%). There was a high school enrolment rate 
for children aged 5–9 years (median: 99%; range: 95– 
100%, Table 4).
Discussion
The implementation of population-based prevalence 
survey protocols in Brazil, using internationally standar-
dised and endorsed methodologies,16,17 allowed us to 
estimate as accurately as possible the trachoma preva-
lence in the at-risk non-indigenous Brazilian popula-
tion. The findings of this study are highly encouraging 
in the context of Brazil’s fight to eliminate trachoma as a 
public health problem.
Although the selected survey areas did not cover the 
whole country, these nine EUs, formed within rural 
areas of high social and/or epidemiological risk, were 
chosen because they represented the non-indigenous 
locations of Brazil most likely to have trachoma. Given 
that the prevalence of TF was ≤1% in all nine EUs, we 
infer that the non-indigenous population of Brazil no 
longer has active trachoma at levels constituting a public 
health problem.
Among the possible explanations for the fact that tra-
choma appears to have disappeared in non-indigenous 
Brazil are the social and economic development of the 
country, with expansion of urban infrastructure and 
increased schooling of the young Brazilian population.34 
Since the implementation of the National Program to 
Support the Collection of Rainwater and other Social 
Technologies (Cisterns Program) in 2003, focused on 
promoting access to water for human consumption, 
more than one million cisterns have been installed in 
semi-arid Brazil, with priority given to low-income rural 
families affected by drought or regular lack of water 
(http://mds.gov.br/assuntos/seguranca-alimentar/acesso- 
a-agua-1/programa-cisternas). According to data from 
the 2000 Demographic Census and the National Health 
Survey 2013, between these two time points, the percen-
tage of households with piped water increased from 15.7 
to 58.2% in the rural North, and from 16.5 to 55.8%, in the 
rural Northeast. The data presented here are consistent 
with the 2013 data: the proportion of households with an 
improved water source within 30 minutes of the house 
was 43–86% in the EUs surveyed. Regarding schooling, 
according to data from the National Household Sample 
Survey 2018, the schooling rate of 6–14-year-olds in 2018 
was 99.3% for Brazil as a whole, 98.9% in the North and 
99.2% in the Northeast (https://www.ibge.gov.br/estatisti 
cas/sociais/trabalho/17270-pnad-continua.html?edicao= 
24772&t=resultados). In the surveys presented here, 
≥95% of children aged 5–9 years reported regularly 
attending school.
In the late 1990’s, the Family Health Strategy was 
implemented as a national policy for primary care, 
giving priority to socially disadvantaged areas.35 Since 
its implementation, healthcare coverage has increased 
in all Brazilian regions and has been associated with a 
reduction in health problems treated under primary 
care. From 2007 to 2020, the proportion of people 
receiving regular visits from community health work-
ers increased from 48.0 to 76.5% in Brazil, from 56.2 to 
73.2%, in the North and from 75.0 to 86.5% in the 
Northeast (https://egestorab.saude.gov.br/). In our sur-
veys, the poprotion of households reporting regular 
community health worker visits was >60% in 8/9 EUs; 
only in Norte de Roraima was a low percentage (36%) 
found. Strengthening of trachoma surveillance actions 
after the previous school-based surveys27 have led to 
the identification of endemic areas, improved access to 
diagnosis of trachoma, improved delivery of educa-
tional activities aimed at reducing the transmission of 
C. trachomatis,36,37 and improved access to antibiotics, 
including azithromycin, to treat trachoma and other 
conditions. All of these activities could have contribu-
ted to a substantial decline in trachoma prevalence in 
Brazil.
In the 2000s, government cash transfer programs, 
such as Bolsa Família, led to changes in income distribu-
tion and showed important impacts on health 
conditions,38 including a decrease in the incidence of 
some neglected tropical diseases.39 Thus, in addition to 
facilitating trachoma surveillance, public policies 
focused on decreasing social inequality may have con-
tributed to reductions in trachoma in Brazil.
Only one EU (Noroeste Cearense) had a TT prevalence 
unknown to the health system ≥0.2% in ≥15-year-olds, 
and in that EU it was only 0.22% (95%CI 0.1–0.4%). One 
interpretation of this result would be that Noroeste 
Cearense still requires public health-level surgical service 
provision to achieve the TT elimination prevalence 
threshold, to be provided through collaboration between 
the health system of the state of Ceará, the Federal 
Ministry of Health, and relevant professional bodies. 
This could include measures to raise awareness among 
the general population about the availability of ophthal-
mic services, to identify cases and to ensure appropriate 
referral to certified surgeons, developing a collaborative 
plan to deal with the burden of trachomatous trichiasis in 
the adult population. In estimating the burden of a low 
prevalence condition, however, in which the confidence 
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intervals of most estimates include zero, there is an inher-
ent tendency for overestimation. The relative uncertainty 
of EU-level TT prevalence estimates is recognized,40 but is 
difficult to overcome using a frequentist statistical 
approach without the use of prohibitively large sample 
sizes. Further work, such as geospatial analysis of disease 
distribution should be undertaken on the data from these 
nine EUs before resources are deployed on a response in 
Noroeste Cearense that may or may not be required.
In addition to generating data on trachoma in 
each of the nine EUs, making it possible to assess 
an epidemiological situation of trachoma in Brazil, 
these surveys were valuable in requiring standardised 
training for trachoma diagnosis in accordance with 
WHO recommendations. Over 30 examiners from 
different states were trained and certified by 
Tropical Data.30 Capacity was also developed in 
Brazil for conducting population-based surveys 
using rigorous, internationally standardised 
approaches. Teams were able to complete surveys in 
EUs efficiently; on average, it took 15 days to survey 
an EU even in remote and hard-to-reach areas. This 
combined capacity can be deployed in the future 
should concerns about trachoma re-emerge, and 
could also be applied to surveys focussed on other 
health conditions.
Individuals enrolled in the survey benefitted from 
early detection of trachoma, making it possible to 
treat TF cases and family contacts at the time of 
the research, and referral of identified cases of TT 
to ophthalmic services. Moreover, the findings on 
access to WASH provide important supplementary 
information for public bodies looking to overcome 
social inequality.41
Indigenous communities were not included in this 
study. Future surveys are being planned in those popula-
tions, to help complete the mapping of trachoma preva-
lence in Brazil. In the meantime, Brazilian health 
authorities will work closely with WHO to ensure appro-
priate approaches are deployed to progress the agenda of 
elimination of trachoma as a public health problem.
Conclusions
The prevalence of TF was well below the target for elim-
ination as a public health problem in all non-indigenous 
surveyed EUs. Because these EUs were selected to repre-
sent the highest-risk non-indigenous areas of the country, 
TF prevalence is unlikely to be ≥5% in non-indigenous 
populations elsewhere. In one EU, the prevalence of TT 
was above the target threshold for elimination. Further 
investigation and possibly improvement in TT surgical 
provision are required in that EU.
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